Antibodies, Antineutrophil Cytoplasmic: Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.Wegener Granulomatosis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and kidneys. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against neutrophil proteinase-3 (WEGENER AUTOANTIGEN).Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.Myeloblastin: A polymorphonuclear leukocyte-derived serine protease that degrades proteins such as ELASTIN; FIBRONECTIN; LAMININ; VITRONECTIN; and COLLAGEN. It is named for its ability to control myeloid cell growth and differentiation.Antibodies: Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).Antibody Specificity: The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.Peroxidase: A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7.Antibodies, Viral: Immunoglobulins produced in response to VIRAL ANTIGENS.Antibodies, Monoclonal: Antibodies produced by a single clone of cells.Churg-Strauss Syndrome: Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.Antibodies, Bacterial: Immunoglobulins produced in a response to BACTERIAL ANTIGENS.Microscopic Polyangiitis: A primary systemic vasculitis of small- and some medium-sized vessels. It is characterized by a tropism for kidneys and lungs, positive association with anti-neutrophil cytoplasmic antibodies (ANCA), and a paucity of immunoglobulin deposits in vessel walls.Propylthiouracil: A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)Fluorescent Antibody Technique, Indirect: A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)Vasculitis, Leukocytoclastic, Cutaneous: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.Autoantibodies: Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.Antithyroid Agents: Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.Antibody Formation: The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.Antibodies, Neutralizing: Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.Fluorescent Antibody Technique: Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.Neutrophils: Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.Serine Endopeptidases: Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis.Polyarteritis Nodosa: A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME.Antibodies, Antinuclear: Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.Enzyme-Linked Immunosorbent Assay: An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.Antibody Affinity: A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.Antibodies, Anti-Idiotypic: Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.Antibodies, Fungal: Immunoglobulins produced in a response to FUNGAL ANTIGENS.Immunoglobulin G: The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.Binding Sites, Antibody: Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS.Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.HIV Antibodies: Antibodies reactive with HIV ANTIGENS.Endocarditis, Subacute Bacterial: ENDOCARDIUM infection that is usually caused by STREPTOCOCCUS. Subacute infective endocarditis evolves over weeks and months with modest toxicity and rare metastatic infection.Immunosuppressive Agents: Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.Epitopes: Sites on an antigen that interact with specific antibodies.Antibodies, Neoplasm: Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS.Antibodies, Protozoan: Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.Purpura, Schoenlein-Henoch: A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.Autoantigens: Endogenous tissue constituents that have the ability to interact with AUTOANTIBODIES and cause an immune response.Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.Antibodies, Monoclonal, Murine-Derived: Antibodies obtained from a single clone of cells grown in mice or rats.Immune Sera: Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.Lysosomal-Associated Membrane Protein 2: An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.Neutrophil Activation: The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.Biological Markers: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.Cross Reactions: Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.Methimazole: A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.Cyclophosphamide: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.Fixatives: Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents. They must quickly kill and coagulate living tissue.Nose Diseases: Disorders of the nose, general or unspecified.Respiratory Burst: A large increase in oxygen uptake by neutrophils and most types of tissue macrophages through activation of an NADPH-cytochrome b-dependent oxidase that reduces oxygen to a superoxide. Individuals with an inherited defect in which the oxidase that reduces oxygen to superoxide is decreased or absent (GRANULOMATOUS DISEASE, CHRONIC) often die as a result of recurrent bacterial infections.Cathepsin G: A serine protease found in the azurophil granules of NEUTROPHILS. It has an enzyme specificity similar to that of chymotrypsin C.Eosinophilia-Myalgia Syndrome: A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)Immunoglobulin M: A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.Focal InfectionLung Diseases: Pathological processes involving any part of the LUNG.Plasma Exchange: Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.Neutralization Tests: The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).Scleritis: Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)Hemoptysis: Expectoration or spitting of blood originating from any part of the RESPIRATORY TRACT, usually from hemorrhage in the lung parenchyma (PULMONARY ALVEOLI) and the BRONCHIAL ARTERIES.Proctocolectomy, Restorative: A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR (pouch). In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.Methylprednisolone: A PREDNISOLONE derivative with similar anti-inflammatory action.Recurrence: The return of a sign, symptom, or disease after a remission.Antigen-Antibody Reactions: The processes triggered by interactions of ANTIBODIES with their ANTIGENS.Pancreatic Elastase: A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36.Antibodies, Bispecific: Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.Molecular Sequence Data: Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.Drug Contamination: The presence of organisms, or any foreign material that makes a drug preparation impure.Single-Chain Antibodies: A form of antibodies consisting only of the variable regions of the heavy and light chains (FV FRAGMENTS), connected by a small linker peptide. They are less immunogenic than complete immunoglobulin and thus have potential therapeutic use.Mice, Inbred BALB CAntibodies, Blocking: Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989)Amino Acid Sequence: The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.Biopsy: Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.Antigen-Antibody Complex: The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.Immunoglobulin Fab Fragments: Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.Remission Induction: Therapeutic act or process that initiates a response to a complete or partial remission level.Antibodies, Heterophile: Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.Antibodies, Catalytic: Antibodies that can catalyze a wide variety of chemical reactions. They are characterized by high substrate specificity and share many mechanistic features with enzymes.Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.Receptors, IgG: Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).Leukocyte Elastase: An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.Lactoferrin: An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion.Rabbits: The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.Immunoglobulin A: Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.Antibodies, Monoclonal, Humanized: Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.Hybridomas: Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell.Formaldehyde: A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717)Flow Cytometry: Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.Kidney: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.Epitope Mapping: Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Hemorrhage: Bleeding or escape of blood from a vessel.Antibodies, Antiphospholipid: Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.Immunization: Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).alpha 1-Antitrypsin: Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.Glucocorticoids: A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Antigens: Substances that are recognized by the immune system and induce an immune reaction.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)Immunoenzyme Techniques: Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.Necrosis: The pathological process occurring in cells that are dying from irreparable injuries. It is caused by the progressive, uncontrolled action of degradative ENZYMES, leading to MITOCHONDRIAL SWELLING, nuclear flocculation, and cell lysis. It is distinct it from APOPTOSIS, which is a normal, regulated cellular process.Cell Line: Established cell cultures that have the potential to propagate indefinitely.Antigens, Bacterial: Substances elaborated by bacteria that have antigenic activity.Cytoplasm: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)Drug Therapy, Combination: Therapy with two or more separate preparations given for a combined effect.Antigens, Surface: Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.Predictive Value of Tests: In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.Immunization, Passive: Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).Recombinant Proteins: Proteins prepared by recombinant DNA technology.Cathepsins: A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES.Blotting, Western: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.Immunoassay: A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.Immunoglobulin Fragments: Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques.Molecular Weight: The sum of the weight of all the atoms in a molecule.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Antigens, Viral: Substances elaborated by viruses that have antigenic activity.Immunoblotting: Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.Radioimmunoassay: Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.Cells, Cultured: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.Electrophoresis, Polyacrylamide Gel: Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.B-Lymphocytes: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.Pulmonary Alveoli: Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.Tumor Necrosis Factor-alpha: Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.Complement Fixation Tests: Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.Lung: Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.Hemagglutination Tests: Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Hemagglutination Inhibition Tests: Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.Immunoglobulin Variable Region: That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions.Seroepidemiologic Studies: EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.Immunoglobulin Idiotypes: Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains.T-Lymphocytes: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.Immunologic Techniques: Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies.Antigens, Neoplasm: Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.Disease Progression: The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.Base Sequence: The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.Immunosorbent Techniques: Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody.Haptens: Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response.

Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. (1/823)

We describe a patient who presented with Wegener's granulomatosis associated with antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3 (PR3) with a cytoplasmic immunofluorescence pattern (cANCA), whose ANCA type changed to antimyeloperoxidase antibodies with a perinuclear immunofluorescence pattern (pANCA) when treated with propylthiouracil, and changed back to anti-PR3 antibodies with cANCA after the medication was discontinued. The patient developed flares of vasculitis symptoms associated with rises in either type of ANCA. Tests for antimyeloperoxidase ANCA were repeatedly negative before the drug was started, strongly implicating the drug as the cause of the episode. This case demonstrates that patients with idiopathic ANCA-positive vasculitis may quickly develop a superimposed drug-associated ANCA-positive vasculitis. Iatrogenic vasculitis should be suspected when a patient with idiopathic vasculitis with one type of ANCA develops the other type of ANCA.  (+info)

Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. (2/823)

BACKGROUND: In neutrophil trafficking, the role of interleukin-8 (IL-8) is location dependent. Tissue IL-8 directs transmigration, whereas intravascular IL-8 frustrates this process. The bystander damage of glomerular endothelium by antineutrophil cytoplasmic autoantibody (ANCA)-activated neutrophils is believed to be an early event in the pathogenesis of ANCA-associated glomerulonephritis. We have studied the role of IL-8 in this process. METHODS: Intraglomerular expression of IL-8 in patients with ANCA-associated glomerulonephritis was studied by in situ hybridization and immunohistochemistry and location of neutrophils by serial section immunohistochemistry. In vitro, we analyzed ANCA-stimulated neutrophil IL-8 production by enzyme-linked immunosorbent assay, and the IL-8 attributable effect of ANCA-stimulated neutrophil supernatant by chemotactic and transendothelial assays. RESULTS: There was intraglomerular expression of IL-8 at segmental, crescentic, and parietal epithelial sites. IL-8 protein expression colocalized to intraglomerular neutrophils; many localized within glomerular capillary loops, suggesting failed trafficking to tissue IL-8. ANCAs differentially stimulated time- and dose-dependent neutrophil IL-8 production, and ANCA-stimulated neutrophil supernatant demonstrated potent IL-8-dependent chemotactic activity and inhibited transendothelial migration of normal human neutrophils toward an IL-8 gradient. CONCLUSION: Despite heavy tissue expression of IL-8 in ANCA-associated GN, the production of IL-8 by ANCA-stimulated neutrophils within the intravascular compartment may frustrate neutrophil transmigration, encourage intravascular stasis, and contribute to bystander damage of glomerular endothelial cells.  (+info)

Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. (3/823)

The majority of patients with rapidly progressive crescentic glomerulonephritis show histologic features of extensive necrosis and focal and segmental proliferation with fibrin production, but little or absent Ig deposition in the glomerulus. This subcategory of the disease, labeled "pauci-immune" glomerulonephritis, has recently been shown to be associated with the presence of antineutrophil cytoplasmic antibody in the patient's circulation (but not within the glomerulus). The absence of the effectors of humoral immunity at the site of renal injury led to this investigation of the contribution of cell-mediated immunity to the glomerular injury in this form of glomerulonephritis. In 15 patients presenting acutely with pauci-immune glomerulonephritis, CD3-positive T cells (3.7+/-2.5 [mean +/- SD] cells per glomerular cross section, [c/gcs]), CD45RO-positive T cells (2.7+/-1.9 c/cgs), macrophages (7.3+/-6.1 c/gcs), fibrin (3+), and endothelial-associated tissue factor were demonstrated to be prominent in glomeruli. These mediators were absent in a group of 12 patients with thin basement membrane disease and only occasionally observed in a group of eight patients with "humorally mediated"(noncrescentic) glomerulonephritis. Thus, in pauci-immune glomerulonephritis, there is the development of significant cell-mediated immunity with activated T cells, macrophages, tissue factor, and fibrin at the site of glomerular injury, suggesting that this glomerular disease is most likely a manifestation of T cell-directed cognate immune injury.  (+info)

Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. (4/823)

OBJECTIVE: To retrospectively analyze the clinical symptoms, laboratory findings, and outcomes in patients with microscopic polyangiitis (MPA) who were enrolled in various clinical trials conducted by the French Vasculitis Study Group. METHODS: A cohort of 85 patients meeting the Chapel Hill criteria for MPA participated in the study. Seventy-one of them were included in prospective therapeutic trials. Eighty-one diagnoses were biopsy proven. In the other patients, diagnosis was based on clinical findings. RESULTS: Forty-seven men and 38 women, with a mean +/- SD age of 56.8 +/- 14.6 years, met the criteria for MPA. Their main clinical symptoms were renal manifestations (78.8%), weight loss (72.9%), skin involvement (62.4%), fever (55.3%), mononeuritis multiplex (57.6%), arthralgias (50.6%), myalgias (48.2%), hypertension (34.1%), lung involvement (24.7%; alveolar hemorrhage 11.8%), and cardiac failure (17.6%). The mean +/- SD serum creatinine level before treatment was 2.59 +/- 2.96 mg/dl; 47 patients had renal insufficiency (serum creatinine > 1.36 mg/dl). Eight patients underwent dialysis at the time of diagnosis, and long-term dialysis was necessary for 10 patients. Antineutrophil cytoplasmic antibodies (ANCA) were present in 38 of 51 patients (74.5%), of whom 33 had a perinuclear staining pattern (pANCA) and 5 had a cytoplasmic pattern. Antibodies to proteinase 3 were present in 4 patients and antibodies to myeloperoxidase were detected in 31, as determined by enzyme-linked immunosorbent assay. Of the 30 patients who underwent renal and celiac angiography, 4 had microaneurysms. Of the 29 patients (34.1%) who had relapses, 8 died during or after the relapse. During followup, 28 of the 85 patients (32.9%) died. The mean +/- SD duration of followup of the group was 69.9 +/- 60.6 months. Deaths were less frequent when patients had been treated with steroids and immunosuppressive drugs (13 patients [24.1%]) than with steroids alone (15 patients [48.4%]) (P < 0.01). The 5-year survival rate was 74%. CONCLUSION: This study demonstrated that MPA is a multisystemic disease in which renal symptoms are frequent, but the disease is also associated with general symptoms, arthritis, mononeuritis multiplex, and other manifestations that are also seen in various vasculitides. The rarity of abnormal angiogram findings and the high frequency of pANCA are characteristic of MPA. In most cases, the outcome is comparable with those of other systemic vasculitides, but relapses are frequent.  (+info)

Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. (5/823)

BACKGROUND AND OBJECTIVE: The key pathogenic feature of TTP is the formation of platelet aggregates within the microcirculation; however, the etiology of such aggregates has been elusive for years. A large amount of evidence points to an abnormal interaction between damaged vascular endothelium and platelets, although the cause of the primary microvascular endothelial cell injury is seldom clear. The autoimmune hypothesis often recurs, and this is based on a number of observations: the claimed superiority of plasma-exchange over plasma infusion, the anecdotal report of the presence of immunocomplexes and autoantibodies in TTP patients, the efficacy of the administration of corticosteroids and other immunosuppressant agents, and the concomitant occurrence of TTP in association with autoimmune diseases, especially systemic lupus erythematosus (SLE). This review will focus on the complex relationships between TTP and humoral autoimmunity; in particular, similarities and differences between TTP, SLE and antiphospholipid (aPL) antibodies syndrome, as well as the putative role of several other antibodies directed towards endothelial cells and/or platelets, including the recently discovered anti-CD36 antibodies and antivWF-cleaving metalloprotease, will be discussed. DESIGN AND METHODS: The authors have been involved in the study and treatment of TTP and autoimmune diseases for years; furthermore, the PubMed data base of the National Library of Congress has been extensively searched using the Internet. CONCLUSIONS: Although over the years evidence has increased in favor of the autoimmune hypothesis for TTP etiopathogenesis, TTP should not yet be considered an autoimmune disease. Autoantibodies should be regarded as only one of the many different insults which can trigger microvascular thrombosis even though the autoimmune theory of the pathogenesis of TTP is gaining more and more strength. As far as concerns the relationship between TTP, SLE and aPL antibodies-related disorders, these diseases should be distinguished on the basis of both different clinical presentations and accurate antibody screening, although this approach should definitely not delay the prompt start of treatment.  (+info)

Wegener's granulomatosis associated with renal cell carcinoma. (6/823)

OBJECTIVE: To determine the frequencies and types of malignant neoplasms occurring before or simultaneously with the diagnosis of Wegener's granulomatosis (WG), and to test for the presence of "Wegener's autoantigen," proteinase 3 (PR3), in malignant tissues from WG patients to ascertain whether an association exists between malignancy and WG. METHODS: A retrospective statistical analysis was performed on the medical records of 477 patients with WG as compared with a control group of 479 patients with rheumatoid arthritis (RA). A murine monoclonal antibody was used to test malignant tissues for the presence of PR3. RESULTS: A malignant neoplasm was found in 23 patients in the WG group and in 18 patients in the control group. The odds ratio for malignant neoplasm in the WG group was 1.79 (P = 0.0876, 95% confidence interval [95% CI] 0.92-3.48). Seven patients with renal cell carcinoma were found in the WG group compared with 1 patient in the control group, for an odds ratio of 8.73 (P = 0.0464, 95% CI 1.04-73.69). Simultaneous occurrence of cancer and WG was observed in 14 patients with WG compared with 1 control patient, for an odds ratio of 18.00 (P = 0.0059, 95% CI 230-140.67). Furthermore, the diseases occurred simultaneously in 5 of the 7 patients with both WG and renal cell carcinoma, but not in the single patient in the control group with RA and renal cell carcinoma. PR3 could not be detected in any of the 8 malignant tissue samples (4 renal cell carcinomas) investigated in the patients from the WG group. CONCLUSION: The close temporal association between renal cell carcinoma and WG suggests that malignancy is, in some cases, a trigger for the development of WG. However, since PR3 was not found in malignant tissues from the WG patients, the immunopathologic mechanisms leading to autoimmunity and vasculitis remain unclear.  (+info)

Expression of major histocompatibility class II antigens on polymorphonuclear neutrophils in patients with Wegener's granulomatosis. (7/823)

BACKGROUND: Wegener's granulomatosis is a systemic inflammatory disease of unknown etiology. Many studies suggest that autoimmune reactions are involved, and there is good evidence for the participation of immunocompetent cells. In that context, we examined the activation of polymorphonuclear neutrophils (PMNs) of patients with Wegener's granulomatosis. METHODS: In a prospective study, the expression on the surface of PMNs of CD64 and of the major histocompatibility class II (MHC II) antigen was measured by cytofluorometry in whole blood. The expression of those antigens was correlated to disease activity. RESULTS: Up to 15% of the peripheral PMNs of patients with active disease expressed MHC II. Follow-up studies showed that expression correlated closely with disease activity and that it decreased rapidly under immunosuppressive therapy. Expression of CD64 was seen in approximately 50% of the patients, regardless of disease activity. CONCLUSION: MHC II expression on PMNs might serve as a novel diagnostic marker for active disease and appears to be suitable for monitoring immunotherapy. Moreover, our data provide evidence that PMNs, which are normally MHC II negative, acquire MHC II antigens in the course of disease and may be an unrecognized function within the afferent limb of the immune response.  (+info)

Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA. (8/823)

PURPOSE: A subset of patients with anterior uveitis express the marker, perinuclear anti-neutrophil cytoplasmic antibody (pANCA). In this study, recombinantly isolated pANCA monoclonal antibodies were used to search for ocular cells expressing the pANCA antigen. METHODS: Paraffin sections of human ocular tissues obtained after death were analyzed by immunohistochemistry to identify cell types expressing pANCA antigen. Microdissected eye-bank ocular tissue was characterized by western blot analysis to confirm antigen expression and identify candidate protein species. RESULTS: Immunohistochemical analysis with pANCA monoclonal antibodies revealed cytoplasmic antigen expression in retinal ganglion cells and ciliary body epithelium. pANCA antigen expression was restricted to tissues bearing these cell types by western blot analysis. A common set of epitope-positive protein species was shared by the two tissues (28 kDa, 80 kDa, and 90 kDa). Comparison of ocular tissues from seven subjects revealed no heterogeneity in antigen expression. CONCLUSIONS: In this study, novel cytoplasmic antigens of the pANCA marker antibody expressed in ciliary body and retinal tissue were identified. Validation of these antigens as targets of inflammation in pANCA+ uveitis requires further biochemical and immunologic analysis.  (+info)

*Eosinophilic granulomatosis with polyangiitis

Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007). "Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: a ... Diagnostic markers include eosinophil granulocytes and granulomas in affected tissue, and antineutrophil cytoplasmic antibodies ...

*Anti-neutrophil cytoplasmic antibody

Sinclair, D; Stevens, JM (Sep 2007). "Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies ... Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies, mainly of the IgG type, against antigens in the ... images of pANCA and cANCA fluorescence images of ANCA Anti-Neutrophil Cytoplasmic Antibody at the US National Library of ... Savige, J; Davies, D; Falk, RJ; Jennette, JC; Wiik, A (Mar 2000). "Antineutrophil cytoplasmic antibodies and associated ...

*Granulomatosis with polyangiitis

Determination of Anti-neutrophil cytoplasmic antibodies (ANCAs) can aid in the diagnosis, but positivity is not conclusive and ... It is now widely presumed that the anti-neutrophil cytoplasmic antibodies (ANCAs) are responsible for the inflammation in GPA. ... Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007). "Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a ... antineutrophil cytoplasmic antibodies) against small and medium-size blood vessels. Apart from GPA, this category includes ...

*P-ANCA

... , or MPO-ANCA, or Perinuclear Anti-Neutrophil Cytoplasmic Antibodies, are antibodies that stain the material around the ... They are a special class of Anti-Neutrophil Cytoplasmic Antibodies. This pattern occurs because the vast majority of the ... Focal necrotizing and crescentic glomerulonephritis Rheumatoid arthritis C-ANCA Anti-Neutrophil Cytoplasmic Antibody (ANCA) ... Antibody staining therefore results in fluorescence of the region around the nucleus. p-ANCAs stain the perinuclear region by ...

*Vasculitis

Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L (2013) Antineutrophil cytoplasmic antibody-associated ... Other possible findings are elevated antineutrophil cytoplasmic antibody (ANCA) levels and hematuria. Other organ functional ... Several of these vasculitides are associated with antineutrophil cytoplasmic antibodies. These are: Granulomatosis with ... In these cases, the antibody found is sometimes used in classification, as in ANCA-associated vasculitides. Location of the ...

*Necrotizing vasculitis

Antineutrophil cytoplasmic antibody (ANCA) may highly suggest granulomatosis with polyangiitis, microscopic polyangiitis, ... Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007). "Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a ... A systematic review of antineutrophil cytoplasmic antibody (ANCA) positive vasculitis identified best treatments depending on ... Additional, more specific tests include: Antinuclear antibody (ANA) test can detect an underlying connective tissue disorder, ...

*Myeloperoxidase

Antibodies are also known as anti-neutrophil cytoplasmic antibodies (ANCAs), though ANCAs have also been detected in staining ... Flint SM, McKinney EF, Smith KG (Mar 2015). "Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody- ... Antibodies against MPO have been implicated in various types of vasculitis, most prominently three clinically and ... Leong A S-Y, Cooper K, Leong, FJ W-M (2003). Manual of Diagnostic Antibodies for Immunohistology. London: Greenwich Medical ...

*Crohn's disease

Testing for Saccharomyces cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA) has been evaluated to ... "Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease". Gut. 54 ( ... Both the endomysial antibody and tissue transglutaminase antibody have very high sensitivities (93% for both) and specificities ... The long term safety and effectiveness of monoclonal antibody treatment is not known. The monoclonal antibody briakinumab is ...

*HLA-A1

A1-B58 haplotype (A1-B17 where B58 is dominant) may remain associated with anti-neutrophil cytoplasmic antibody (ANCA) With the ... "Immunogenetic association in patients with antineutrophil cytoplasmic antibodies (ANCA) from Mumbai, Maharashtra, India". J ... The serotype is determined by the antibody recognition of α1 subset of HLA-A α-chains. For A1, the alpha "A" chain are encoded ...

*Anti-Saccharomyces cerevisiae antibody

ASCAs and perinuclear antineutrophil cytoplasmic antibodies (pANCAs) are the two most useful and often discriminating ... 2007). "Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies ... Anti-Saccharomyces cerevisiae antibodies (ASCAs) are antibodies against antigens presented by the cell wall of the yeast ... ASCA antibodies react to a yeast protein with mannans, a 200-kDa glycoprotein. Diseases in which ASCA are found include the ...

*Hypereosinophilia

Zhang J, Zhang HY, Chen SZ, Huang JY (2016). "Anti-neutrophil cytoplasmic antibodies in cholesterol embolism: A case report and ... elevated blood levels of IgM antibodies, and clonal expansion of T cells. Similar to lymphocyte=variant hypereosinophilia, the ...

*Rapidly progressive glomerulonephritis

... antineutrophil cytoplasmic antibodies specificity is determined via (ELISA), with pANCA(antibody) directed against MPO Serum ... In the pathophysiology of rapidly progressive glomerulonephritis the antineutrophil cytoplasmic antibodies (ANCA) interact with ... and type III and idiopathic RPGN are frequently associated with anti-neutrophil cytoplasmic antibodies (ANCA)-positive serum. ... In addition to the anti-GBM antibodies, some cases of type I RPGN are also associated with antibodies directed against the ...

*Primary sclerosing cholangitis

For example, approximately 80% of people with PSC have perinuclear anti-neutrophil cytoplasmic antibodies; however, this and ... Antinuclear antibodies and anti-smooth muscle antibody are found in 20%-50% of PSC patients and, likewise, are not specific for ... Simtuzumab is a monoclonal antibody against the pro-fibrotic enzyme LOXL2 that is being developed as a possible therapy for PSC ...

*C-ANCA

... s, or PR3-ANCA, or Cytoplasmic antineutrophil cytoplasmic antibodies, are a type of autoantibody, an antibody produced by ... P-ANCA Anti-Neutrophil Cytoplasmic Antibody (ANCA) Thomas M. Habermann (26 June 2006). Mayo Clinic internal medicine review, ... These antibodies show a diffusely granular, cytoplasmic staining pattern under microscopy. This pattern results from binding of ...

*FCGR3B

... anti-neutrophil cytoplasmic antibody-induced release of chemotaxins". Journal of Immunology. 171 (11): 6090-6. doi:10.4049/ ...

*GJB6

1996). "Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody ...

*Drug-induced lupus erythematosus

Antinuclear antibodies are usually positive in drug induced Lupus. Anti-Neutrophil Cytoplasmic antibodies (ANCA) can also be ... Furthermore, Anti-Histone antibodies can also be positive in drug induced lupus. Anti-Histone antibodies are positive in up to ... Anti-histone antibodies in 95% of cases These signs and symptoms are not side effects of the drugs taken which occur during ... Anti-histone antibody Lupus erythematosus Hydralazine Discoid lupus erythematosus List of cutaneous conditions Rubin, Robert L ...

*Pauci-immune

... a pauci-immune pattern finding can be associated with antineutrophil cytoplasmic antibodies (ANCA). Therefore, an ANCA test ...

*Hepatitis

... smooth muscle antibody (SMA), and atypical perinuclear antineutrophil cytoplasmic antibody (p-ANCA). Other autoantibodies that ... anti-viral antibodies (such as the anti-hepatitis B surface antibody or anti-hepatitis A antibody), or viral DNA/RNA. In early ... Auto-antibodies found in patients with autoimmune hepatitis include the sensitive but less specific anti-nuclear antibody (ANA ... Therefore, when a patient is positive for IgG antibody but negative for IgM antibody, he is considered immune from the virus ...

*Ronald J. Falk

March 2012). "Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody ... As an investigator, Falk studies kidney diseases caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs), which are a ... Falk, RJ; Terrell, RS; Charles, LA; Jennette, JC (June 1990). "Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to ... The UNC group concluded that anti-LAMP-2 antibodies are identifiable, low titer, natural or induced antibodies occasionally ...

*Proteinase 3

It is also the target of anti-neutrophil cytoplasmic antibodies (ANCAs) of the c-ANCA (cytoplasmic subtype) class, a type of ... Lüdemann J, Utecht B, Gross WL (1990). "Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an ... Ohlsson K, Linder C, Rosengren M (1990). "Monoclonal antibodies specific for neutrophil proteinase 4. Production and use for ... antibody frequently found in the disease granulomatosis with polyangiitis (formerly known as "Wegener's granulomatosis"). ...

*ANCA

Romanian female first name Antarctic Names Committee of Australia Anti-neutrophil cytoplasmic antibody, proteins detected in a ...

*Microscopic polyangiitis

An important diagnostic test is the presence of perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) with myeloperoxidase ... October 2002). "Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis ... These antibodies will circulate at low levels until a pro-inflammatory trigger - such as infection, malignancy, or drug therapy ... Then, the large number of antibodies make it more likely that they will bind a neutrophil. Once bound, the neutrophil ...

*List of MeSH codes (D12.776)

... antibodies, antineutrophil cytoplasmic MeSH D12.776.377.715.548.114.323.204 - antibodies, antinuclear MeSH D12.776.377.715. ... antibodies MeSH D12.776.377.715.548.114.071 - antibodies, anti-idiotypic MeSH D12.776.377.715.548.114.107 - antibodies, ... antibodies, bispecific MeSH D12.776.377.715.548.114.143 - antibodies, blocking MeSH D12.776.377.715.548.114.167 - antibodies, ... antibodies, helminth MeSH D12.776.377.715.548.114.191 - antibodies, heterophile MeSH D12.776.377.715.548.114.224 - antibodies, ...

*List of MeSH codes (D12.776.124)

... antibodies, antineutrophil cytoplasmic MeSH D12.776.124.486.485.114.323.204 -- antibodies, antinuclear MeSH D12.776.124.486. ... antibodies, antineutrophil cytoplasmic MeSH D12.776.124.790.651.114.323.204 -- antibodies, antinuclear MeSH D12.776.124.790. ... antibodies MeSH D12.776.124.486.485.114.071 -- antibodies, anti-idiotypic MeSH D12.776.124.486.485.114.089 -- antibodies, ... antibodies, blocking MeSH D12.776.124.486.485.114.167 -- antibodies, catalytic MeSH D12.776.124.486.485.114.179 -- antibodies, ...

*Anti-nuclear antibody

The Jo-1 antigen and antibody were characterised in 1980. Rheumatoid factor Anti-neutrophil cytoplasmic antibody (ANCA) " ... anti-Sm antibodies, anti-nRNP antibodies, anti-Scl-70 antibodies, anti-dsDNA antibodies, anti-histone antibodies, antibodies to ... This pattern is associated with anti-dsDNA antibodies, antibodies to nucleosomal components, and anti-histone antibodies. There ... Although anti-Jo-1 antibodies are often included with ANAs, they are actually antibodies to the cytoplasmic protein, histidyl ...
A 42-year-old computer programmer presented with jaundice and reported 2 weeks of nonspecific symptoms. Jaundice and hepatomegaly were present. The liver measured 17 cm in the right midclavicular line, and the spleen was not palpable. Serum bilirubin level was 257 µmol/L (15.0 mg/dL) conjugated and 29 µmol/L (1.7 mg/dL) unconjugated, albumin level was 4.2 g/L, globulin level was 2.8 g/L, alanine aminotransferase level was 2800 U/L, aspartate aminotransferase level was 2230 U/L, alkaline phosphatase level was 260 U/L, and prothrombin time was 12.9 seconds. Results of tests for hepatitis A antibody, hepatitis B markers, cytomegalovirus antibody, and mononucleosis were negative. Circulating hepatitis C virus and hepatitis E virus were undetectable by polymerase chain reaction. Antibodies to nuclei, smooth muscle, soluble liver antigen, and liver kidney microsomes-1 were not detected, but atypical perinuclear antineutrophil cytoplasmic antibodies (pANCA) were present at a titer of 1:160. Liver ...
Looking for online definition of Cytoplasmic Antineutrophil Cytoplasmic Antibody in the Medical Dictionary? Cytoplasmic Antineutrophil Cytoplasmic Antibody explanation free. What is Cytoplasmic Antineutrophil Cytoplasmic Antibody? Meaning of Cytoplasmic Antineutrophil Cytoplasmic Antibody medical term. What does Cytoplasmic Antineutrophil Cytoplasmic Antibody mean?
AIMS--To study the effect of proctocolectomy on the antineutrophil cytoplasmic antibody (ANCA) titres in association with ulcerative colitis. METHODS--Serum samples were taken from 15 patients with ulcerative colitis immediately before and at a mean of 24 months after proctocolectomy. Indirect immunofluorescence for ANCA and enzyme immunoassays for myeloperoxidase and proteinase-3 antibodies were employed. A liver biopsy was taken from every patient during the proctocolectomy, and serum liver enzyme activities were also determined. RESULTS--Before proctocolectomy, 13 of the 15 patients had perinuclear antineutrophil cytoplasmic antibodies (p-ANCA). Additionally, one patient had a low tire of classical cytoplasmic ANCA and one had granulocyte specific antinuclear antibodies. After proctocolectomy, the ANCA titres decreased in 10 patients, in two of whom they became negative. The titres remained the same in four patients with positive ANCA and increased twofold in one patient. Only one patient was ...
TY - JOUR. T1 - IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. AU - Kelley, James M.. AU - Monach, Paul A.. AU - Ji, Chuanyi. AU - Zhou, Yebin. AU - Wu, Jianming. AU - Tanaka, Sumiaki. AU - Mahr, Alfred D.. AU - Johnson, Sharleen. AU - McAlear, Carol. AU - Cuthbertson, David. AU - Carette, Simon. AU - Davis, John C.. AU - Dellaripa, Paul F.. AU - Hoffman, Gary S.. AU - Khalidi, Nader. AU - Langford, Carol A.. AU - Seo, Philip. AU - St Clair, E. William. AU - Specks, Ulrich. AU - Stone, John H.. AU - Spiera, Robert F.. AU - Ytterberg, Steven R.. AU - Merkel, Peter A.. AU - Edberg, Jeffrey C.. AU - Kimberly, Robert P.. PY - 2011/12/20. Y1 - 2011/12/20. N2 - Granulomatosis with polyangiitis (Wegeners) is a rare autoimmune neutrophil-mediated vasculitis that can cause renal disease and mucosal manifestations. Antineutrophil cytoplasmic antibodies (ANCA) are present in many patients, vary in level over time, and ...
It was with much interest that we read the letter of Novikov et al 1 on testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with ANCA-associated vasculitides (AAV) and other diseases. In their letter, the authors (1) share their experience with direct testing for proteinase-3 (PR3) ANCA and myeloperoxidase (MPO) ANCA and (2) raise some important issues regarding interpretation of ANCA test results.. Novikov et al 1 abandoned indirect immunofluorescence (IIF) for ANCA screening more than 10 years ago and since then have been directly testing for PR3-ANCA and MPO-ANCA by immunoassay. They identified antibodies in 96.9% of patients with microscopic polyangiitis (MPA), in 72.7% of patients with granulomatosis with polyangiitis (GPA) and in 92.2% of patients with renal GPA. These results are in line with the results obtained in a recent multicentre study by the European Vasculitis Study Group2 and confirm that patients with GPA with localised (limited) disease can be ANCA negative.3 ...
Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies, mainly of the IgG type, against antigens in the cytoplasm of neutrophil granulocytes (the most common type of white blood cell) and monocytes. They are detected as a blood test in a number of autoimmune disorders, but are particularly associated with systemic vasculitis, so called ANCA-associated vasculitides. Immunofluorescence (IF) on ethanol-fixed neutrophils is used to detect ANCA, although formalin-fixed neutrophils may be used to help differentiate ANCA patterns. ANCA can be divided into four patterns when visualised by IF; cytoplasmic ANCA (c-ANCA), C-ANCA (atypical), perinuclear ANCA (p-ANCA) and atypical ANCA (a-ANCA), also known as x-ANCA. c-ANCA shows cytoplasmic granular fluorescence with central interlobular accentuation. c-ANCA (atypical) shows cytoplasmic staining that is usually uniform and has no interlobular accentuation. p-ANCA has three subtypes, classical p-ANCA, p-ANCA without nuclear extension ...
Background: Mycobacterium tuberculosis is a major cause of mortality and morbidity worldwide. Infection with this bacterium is known to induce the development of autoantibodies of which a few are also known to be diagnostic markers for some other diseases. Antineutrophil Cytoplasmic Antibodies (ANCAs) are among those autoantibodies used in clinical setting for diagnosing systemic vasculitic syndromes. Multiple studies investigated ANCA positivity in diseases other than small vessel vasculitis. Objective: This study was performed to determine the prevalence of ANCA in pulmonary tuberculosis (TB) which may lead to the false diagnosis of Wegeners granulomatosis (WG) or vice versa. Methods: In a case-control study, 32 consecutive smear positive pulmonary TB patients and 32 normal individuals were studied. All cases and controls were screened for ANCA by indirect immunofluorescent assay (IIF), and MPO and PR3 were also tested by ELISA. Results: A prenuclear pattern (PANCA) was detected in 25% of the cases
BACKGROUND: Antineutrophil cytoplasmic antibodies (ANCAs) are found in the sera of patients with vasculitides and ulcerative colitis. Using indirect immunofluorescence on ethanol fixed neutrophils, ANCAs can be divided into two types: those that give a cytoplasmic staining pattern (C-ANCA) and those that give a perinuclear staining pattern (P-ANCA). Some studies have indicated that the perinuclear staining pattern might be an artefact of alcohol fixation. AIMS: To observe any changes seen in the ANCA staining pattern using indirect immunofluorescence on unfixed neutrophils or neutrophils that had been fixed by ethanol, acetone, or paraformaldehyde. In addition, the effects of the different fixation methods on the sensitivity of the indirect immunofluorescence test were evaluated. METHODS: Twenty one sera from patients with ulcerative colitis and 19 from healthy controls were studied. In addition, 17 sera from patients with vasculitides, including eight with proteinase 3 (PR 3) positive C-ANCA ...
Antineutrophil Cytoplasmic Antibodies: Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for WEGENER GRANULOMATOSIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
BACKGROUND: Few studies have evaluated the influence of colectomy on antineutrophil cytoplasmic antibody (ANCA) positivity in ulcerative colitis (UC). In small series of patients it has been suggested that ANCA positivity in UC might be predictive for development of pouchitis after colectomy. AIMS: To assess the prevalence of ANCA in UC patients treated by colectomy and a Brookes ileostomy (UC-BI) or ileal pouch anal anastomosis (UC-IPAA), and the relation between the presence of ANCA, the type of surgery, and the presence of pouchitis. SUBJECTS: 63 UC patients treated by colectomy (32 with UC-BI and 31 with UC-IPAA), 54 UC, and 24 controls. METHODS: Samples were obtained at least two years after colectomy. ANCA were detected by indirect immunofluorescent assay. RESULTS: There were no differences between patients with (36.3%) or without pouchitis (35.0%) and between patients with UC (55%), UC-BI (40.6%), and UC-IPAA (35.4%). However, ANCA prevalence significantly decreases in the whole group of ...
Inflammatory bowel disease is a chronic disorder of the lower gastrointestinal tract that may occur in three forms: Crohns disease (CD), ulcerative colitis (UC), and indeterminate colitis (IC). Its prevalence in the adult population approaches 0.3%.1 The differential diagnosis of the different forms of IBD is often difficult, time-consuming, and invasive.2 The gold standard for diagnosis is endoscopy with biopsies for histologic examination.3 In recent years, however, a number of serological markers have been introduced. The most commonly employed serological markers of IBD are anti-Saccharomyces cerevisiae antibody (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibody (pANCA). ASCA positivity is found predominantly in patients with CD, while pANCA positivity is found predominantly in patients with UC.2 A combination of ASCA and pANCA has a specificity of as high as 99% for differentiation of CD from UC.3 Nevertheless, there are a substantial number of patients with IBD who are ...
The authors used indirect immunofluorescence to examine the association of antineutrophil cytoplasmic antibodies (ANCAs) with exposure to asbestos among 61 asbestos-exposed patients (mean exposure = 24.6 yr) and 39 nonexposed controls. ANCA positivit
Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis Journal Articles Refereed ...
Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
An antineutrophil cytoplasmic antibody is a type of protein that is produced by the bodys immune system and is associated with a...
p-ANCA, or MPO-ANCA, or Perinuclear Anti-Neutrophil Cytoplasmic Antibodies, are antibodies that stain the material around the nucleus of a neutrophil. They are a special class of Anti-Neutrophil Cytoplasmic Antibodies. This pattern occurs because the vast majority of the antigens targeted by ANCAs are highly cationic (Positively charged) at pH 7.00. During ethanol (pH ~7.0 in water) fixation, antigens which are more cationic migrate and localize around the nucleus, attracted by its negatively charged DNA content. Antibody staining therefore results in fluorescence of the region around the nucleus. p-ANCAs stain the perinuclear region by binding to specific targets. By far the most common p-ANCA target is myeloperoxidase (MPO), a neutrophil granule protein whose primary role in normal metabolic processes is generation of oxygen radicals. ANCA will less commonly form against alternative antigens that may also result in a p-ANCA pattern. These include lactoferrin; elastase; and cathepsin G. When ...
Results Data for 20 patients were collected; 16 patients had primary MPA (4 boys, 12 girls), with a median age of 8.9 years at the time of disease onset; 4 patients, all female, had antithyroid drug (ATD)-associated MPA, with an age range of 12.5 to 16.2 years at the time of disease onset. All patients exhibited renal involvement. Renal biopsies were performed in 14 patients. Fibrinoid exudation and necrosis of the glomerular capillaries were observed in all biopsy specimens. Crescents and scleroses were noted in 92.9% and 85.7% of these cases, respectively. The most frequent extrarenal organs involved were lungs, followed by the central nervous system (CNS), skin, and digestive system. Ninety percent of patients were positive for perinuclear antineutrophil cytoplasmic antibody, 94.1% were positive for myeloperoxidase, and 88.2% were positive for both. Forty-five percent of the patients had received steroid plus cyclophosphamide (CTX) pulse therapy for more than 3 months, and varying degrees of ...
Objective: To determine whether inhibition of p38 mitogen-activated protein kinase (p38MAPK) reduces the pathogenicity of anti-neutrophil cytoplasmic autoantibodies (ANCAs) in vitro and in vivo. Methods: The effects of the p38MAPK-specific inhibitor AR-447 were studied in vitro using neutrophil respiratory burst and degranulation assays, and in lipopolysaccharide (LPS)-stimulated human glomerular endothelial cells. In vivo, p38MAPK inhibition was investigated in a mouse anti-myeloperoxidase (MPO) IgG/LPS glomerulonephritis model. Mice were treated orally with AR-447 daily, starting before (pretreatment group) or 24 h after disease onset (treatment group), and killed after 1 or 7 day(s). Results: In vitro, AR-447 diminished neutrophil respiratory burst and degranulation induced by patient-derived MPO-ANCA and proteinase 3 (Pr3)-ANCA. In glomerular endothelial cells, AR-447 reduced LPS-induced secretion of IL-6 and IL-8, but not of MCP-1. In mice, pretreatment with AR-447 reduced albuminuria 1 day ...
article{0842b6a5-4378-4713-b668-4454c332e491, abstract = {Wegener granulomatosis (WG) and microscopic polyangiitis (MP), diseases associated with antineutrophil cytoplasmic antibodies (ANCA), had an extremely poor prognosis before the introduction of cyclophosphamide and corticosteroids for their treatment. However, there is still reduced patient survival, and some studies have documented severe side effects of the immunosuppressants used. This 10-yr follow-up study assessed 117 consecutive patients with WG or MP with biopsy-confirmed renal involvement. The cumulative relative patient survival was lower: 0.664 for women and 0.648 for men. The causes of death (n = 64) were in most cases registered as associated with the vasculitic disease. Analysis of possible predictive factors for patient survival by multiple Cox regression analysis revealed that a very high level of proteinase 3 (PR3)-ANCA measured by the capture ELISA method, a diagnosis of MP, and older age were factors predicting poorer ...
ANCA testing should be performed only in the clinical context since PR3-ANCA and MPO-ANCA can be found in the other conditions than vasculitis, for example, infective endocarditis,3 tuberculosis,4 primary sclerosing cholangitis5 and interstitial lung diseases.6 The results of several studies suggest that in such patients, ANCAs have not been merely a chance finding and may be clinically relevant, for example, a high prevalence of ANCAs was identified in unselected patients with infective endocarditis (24%). Seropositive patients presented more commonly with a subacute form of infective endocarditis leading to multiple valve involvement and a more frequent renal impairment.3 Recent evidence indicates that a proportion of patients with idiopathic pulmonary fibrosis who were MPO-ANCA positive at diagnosis or who subsequently seroconverted can develop MPA.7 The incidence of MPA tended to be lower in patients treated than not treated with corticosteroids though the difference did not reach ...
26 of 55 (47%) dogs with confirmed or suspected IMHA and 67 of 140 (48%) dogs seroreactive for vector-borne pathogens had positive results when tested for pANCA. Serum samples with the highest antibody concentrations against L infantum antigen had the highest proportion (28/43 [65%]) that were positive for pANCA. One of 20 (5%) dogs seronegative for tick-borne pathogens and 8 of 22 (36%) dogs seronegative for L infantum had positive results for pANCA. One of 20 (5%) healthy dogs had serum antibodies against pANCA ...
Background and objectives: The overlap between antineutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis (ANCA-GN) and connective tissue diseases (CTD) has been reported mainly as case series in the literature. Frequency of this association, as well as presentation and outcomes are unknown. Materials and Methods: Patients from the Maine-Anjou ANCA-associated vasculitides (AAV) registry with ANCA-GN diagnosed between 01/01/2000 and 01/01/2018, ANCA positivity, and at least six months of follow-up, were included. Results: 106 out of 142 patients fulfilled the inclusion criteria and were analyzed. CTD was present at ANCA-GN diagnosis in 16 (15.1%) patients. The most common CTD were rheumatoid arthritis, Sjogren syndrome and systemic sclerosis. Compared to the control group, females were more represented in the CTD group (75%, p = 0.001). Renal presentation was comparable between groups, including the pathological analysis of renal biopsies. Patients of CTD group presented a higher rate of
CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. . Download books free in pdf. Online library with books, university works and thousands of documents available to read online and download.
We use cookies to ensure that we give you the best experience on our website. If you click Continue well assume that you are happy to receive all cookies and you wont see this message again. Click Find out more for information on how to change your cookie settings ...
Treatment of patients with PR3-ANCA-associated vasculitis consists of two phases: remission induction with highly effective, but also relatively toxic, drugs and, secondly, after remission is achieved, maintenance therapy with less toxic drugs. Currently, remission-maintenance therapy with azathioprine is stopped after approximately 18 months. However, the optimal duration of azathioprine maintenance therapy is unknown.. The investigators have found that patients with PR3-ANCA-associated vasculitis who remain C-ANCA positive after induction of remission have an increased risk to experience relapse of disease (MC Slot et al. Arthritis Rheum. 2004 15;51(2):269-73). Therefore they will test whether relapse risk in these patients can be reduced by extending maintenance therapy at the cost of acceptable therapy related toxicity. After induction of stable remission, ANCA will be measured by IIF. C-ANCA positive patients will be randomized for either standard therapy with azathioprine (until 18 months ...
The antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) are multisystem disorders characterized by necrotizing inflammation of blood vessels, and are associated with an untreated mortality of around 90%1. These disorders include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and renal limited vasculitis (RLV)2.. Renal manifestations of AAV, which commonly include rapidly progressive glomerulonephritis, result in endstage renal failure or death in 40% of patients3. Despite the introduction of newer biological therapies, treatment continues to cause significant morbidity and mortality, and has been associated with more deaths at 1 year than the disease process itself4. A major challenge in the management of patients with renal AAV remains the identification of factors, both clinical and histopathological, which are predictive of response to therapy, risk of relapse, and renal and patient survival. ...
In this study, we investigated the mechanism of platelet activation in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), as well as the activation of the alternative complement pathway by platelets in AAV. CD62P and platelet-leukocyte aggregates in AAV patients were tested by flow cytometry. Platelets were stimulated by plasma from active AAV patients. The effect of the thrombin-protease-activated receptors (PARs) pathway was evaluated by blocking thrombin or PAR1 antagonists. After platelets were activated by plasma from AAV patients, Ca/Mg-Tyrodes buffer and Mg-EGTA buffer were used to measure complement activation in liquid phase and on the surface of platelets. The levels of CD62P-expressing platelets and platelet-leukocyte aggregates were significantly higher in active AAV patients than those in remission and normal controls. Platelets were activated by plasma from active AAV patients (percentage of CD62P-expressing platelets, 97.7 ± 3% vs. 1 ± 0.2%, p | 0
Complement 5a and its receptor C5aR (CD88) are involved in the pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.. This is a randomized, double-blind, active-controlled Phase 3 study to evaluate the safety and efficacy of the orally-administered, selective C5aR inhibitor CCX168 (avacopan) in inducing and sustaining remission in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated concomitantly with Rituximab or Cyclophosphamide/Azathioprine. ...
Journal of Immunology Research is a peer-reviewed, Open Access journal that provides a platform for scientists and clinicians working in different areas of immunology and therapy. The journal publishes research articles, review articles, as well as clinical studies related to classical immunology, molecular immunology, clinical immunology, cancer immunology, transplantation immunology, immune pathology, immunodeficiency, autoimmune diseases, immune disorders, and immunotherapy.
Background Myeloperoxidase (MPO) anti-neutrophil cytoplasm autoantibody (ANCA)-associated vasculitis commonly causes life-threatening pulmonary alveolar hemorrhage or fibrosis. autoantibodies against endothelial cell such as VCAM-1. Then VCAM-1 mediates the adhesion of lymphocytes and monocytes to vascular endothelium. 1 Anti-neutrophil cytoplasm autoantibody (ANCA)-linked illnesses are autoimmune circumstances seen as a necrotizing irritation of small arteries with considerably higher mortality prices than various other autoimmune illnesses (Jones et al. 2010 Nakaya et al. 2013 In ANCA-associated vasculitis (AAV) especially in myeloperoxidase (MPO)-particular ANCA-positive situations the clinical research have been generally centered on renal lesions (Jennette and Falk 2014 Nonetheless it has become apparent that pulmonary lesions such as for example alveolar hemorrhage or fibrosis show up concurrently to renal lesions (Zhang et al. 2014 Furthermore there is really as well as proof to recommend ...
Related Articles Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome. Rheumatology (Oxford). 2019 Jan 01;58(1):103-109 Authors: Wester Trejo MAC, Floßmann ...
Free resource for searching and exporting immune epitopes. Includes more than 95% of all published infectious disease, allergy, autoimmune, and transplant epitope data.
NEURONAL NUCLEAR ANTIBODIES. Antineuronal Nuclear Antibody-Type 1 (ANNA-1). ,1:240. Antineuronal Nuclear Antibody-Type 2 (ANNA-2). ,1:240. Antineuronal Nuclear Antibody-Type 3 (ANNA-3). ,1:240. Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1). ,1:240. NEURONAL AND MUSCLE CYTOPLASMIC ANTIBODIES. Purkinje Cell Cytoplasmic Antibody, Type 1 (PCA-1). ,1:240. Purkinje Cell Cytoplasmic Antibody, Type 2 (PCA-2). ,1:240. Purkinje Cell Cytoplasmic Antibody, Type Tr (PCA-Tr). ,1:240. Amphiphysin Antibody. ,1:240. CRMP-5-IgG. ,1:240. Note: Titers lower than 1:240 are detectable by recombinant CRMP-5 Western blot analysis. CRMP-5 Western blot analysis will be done on request on stored serum (held 4 weeks). This supplemental testing is recommended in cases of chorea, vision loss, cranial neuropathy, and myelopathy. Call the Neuroimmunology Laboratory at 800-533-1710 or 507-266-5700 to request CRMP-5 Western blot.. Neuron-restricted patterns of IgG staining that do not fulfill criteria for amphiphysin, ...
Book Anti Neutrophilic Cytoplasmic Antibody C with Thyrocare Laboratories Ltd online in bangalore at 1mgLabs. Get best prices & free home sample pick up. View online reports and pre-test requirements | 1mgLabs
Dr. Ronald Falk presented the annual NIH Astute Clinician Lecture in early November in the NIH Clinical Center. Falk was introduced by Dr. Francis Collins, director of the NIH, who reflected on his experience learning alongside Falk in medical school.. "I found out during the four years of medical school Ron Falk was an exceptionally intelligent, thoughtful, hard-working, dedicated guy who was going to be undoubtedly a leading physician in the nation. And that turned out to be true," said Collins.. Falk is the chair of the Department of Medicine and a Nan and Hugh Cullman eminent professor at the University of North Carolina Chapel Hill. Through his lecture, "Perspective on Autoimmunity: A View from the ANCA Vasculitis Looking Glass," Falk discussed Anti-Neutrophil Cytoplasmic Autoantibodies (ANCA) vasculitis, a type of autoimmune swelling caused by autoantibodies. A persons immune system helps to fight germs by using normal antibodies in the blood. But some people have abnormal antibodies, ...
A 46-year-old man presented with a 1-week history of right-neck pain. This was preceded by a flulike illness with low-grade fever, chills, fatigue, and myalgia. The pain was aching in character, 3/10 in severity, and aggravated by movement. He had no headache and his vision was normal. Medical history included gastroesophageal reflux disease and occasional migraines.. On examination, the patient was afebrile and normotensive. There was localized swelling and tenderness overlying the right carotid bifurcation. There was no associated lymphadenopathy, and no carotid bruits were audible. White blood cell count, erythrocyte sedimentation rate, C-reactive protein, and autoimmune markers (antinuclear antibodies, antineutrophil cytoplasmic antibody, rheumatoid factor) were all normal. Initial imaging was performed approximately 1 week after symptom onset. Sonography demonstrated a thickened vessel wall and an eccentric soft plaque in the distal right common carotid artery (CCA) extending into the ...
... ,The Anti-MPO - ELISA (P-ANCA) is for the specific detection of MPO antibodies using highly purified myeloperoxidase as antigen. No false-positive results caused by contaminations like lactoferrin or elastase in the antigen preparation. MPO antibodies can not be detected by indirect immunofluorescen,medicine,medical supply,medical supplies,medical product
Dear all does anyone have any experience with getting the Dako anti-neutrophil elastase antibody to work in IHC using paraffin sections? If anyone would be willing to share a protocol I would be greatly indebted! Toshi Akima PhD Student Centre for Transplantation and Renal Research Westmead Millenium Institute Sydney, Australia _______________________________________________ Histonet mailing list [email protected] http://lists.utsouthwestern.edu/mailman/listinfo/histonet ...
There are no specific protocols for Anti-Neutrophil Elastase antibody [11-207.2] (ab41179). Please download our general protocols booklet
Anti-Neutrophil antibody [NIMP-R14] (ab2557) has been cited in 70 publications. References for Human, Mouse in IF, IHC, IHC-Fr, IHC-P
Reactivity: Cow (Bovine), Dog (Canine) Host: Rabbit Clone: Polyclonal 1 image 1 PubMed reference | Order NCF4 antibody (ABIN2782428).
Describes how tests for ANCA/MPO/PR3 are used, when these tests may be ordered, and what the results of tests for ANCA/MPO/PR3 might mean
The Port of Morehead City in North Carolina was closed Tuesday as first responders and emergency management officials addressed a chemical spill of pentaerythritol tetranitrate, the primary ingredient in detonating cords used for industrial explosion
ContextImmunosuppressive therapies for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have greatly advanced patient survival but have turned A
Perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) have been demonstrated in patients with ulcerative colitis and in a higher frequency than expected in their first degree relatives. A hypothesis was proposed that P-ANCA is genetically determined and may represent a subclinical marker of genetic susceptibility to ulcerative colitis. This study analysed P-ANCA in monozygotic twins with inflammatory bowel disease to evaluate this hypothesis further. P-ANCA was analysed with indirect immunofluorescence technique in 12 monozygotic twin pairs with ulcerative colitis and 14 twin pairs with Crohns disease. Furthermore, the study included 21 non-twin patients with ulcerative colitis, 18 non-twin patients with Crohns disease, and 52 healthy controls matched for sex and age. In ulcerative colitis P-ANCA occurred in nine of 14 (64.3%) monozygotic twins and in 13 of 21 (61.9%) non-twin cases, which was significantly different compared with healthy controls who were positive in three of 52 (5.8%) ...
Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis
Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis
Definition of antineutrophil cytoplasmic antibody. Provided by Stedmans medical dictionary and Drugs.com. Includes medical terms and definitions.
BACKGROUND The treatment approaches to antineutrophil cytoplasmic autoantibody (ANCA) small vessel vasculitis expose patients to the risks associated with long-term use of corticosteroids and cytotoxic agents. In an effort to explore approaches to minimize risks, we conducted a pilot efficacy and safety study of mycophenolate mofetil (MMF) in the treatment of subjects with nonlife-threatening recurrent or cyclophosphamide-resistant ANCA-vasculitis. METHODS MMF was initiated at 500 mg orally twice daily and gradually increased to a target dose of 1000 mg twice daily for a duration of 24 weeks. Concomitant therapy with corticosteroids was allowed. The Birmingham Vasculitis Activity Score (BVAS) was used to assess disease activity and treatment efficacy. ANCA titres, serum creatinine and adverse events were secondary measures of efficacy and/or toxicity. RESULTS Twelve subjects were enrolled in the study. Treatment with MMF led to an improvement in disease activity as measured by the BVAS at 24 weeks
TY - JOUR. T1 - Low serum complement 3 level is associated with severe ANCA-associated vasculitis at diagnosis. AU - Choi, Hyeok. AU - Kim, Youhyun. AU - Jung, Seung Min. AU - Song, Jason Jungsik. AU - Park, Yong Beom. AU - Lee, Sang Won. PY - 2019/2/15. Y1 - 2019/2/15. N2 - Objectives: We investigated whether low serum C3 level can cross-sectionally estimate severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in immunosuppressive drug-naïve patients at diagnosis. Methods: We retrospectively reviewed the medical records of 139 patients with AAV, who were first classified as AAV at Severance Hospital. We obtained clinical and laboratory data including serum complement 3 (C3) level and calculated Birmingham vasculitis activity score (BVAS) at diagnosis. We stratified AAV patients into three groups according to the tertile of BVAS and defined the lower limit of the highest tertile as the cutoff for severe AAV (BVAS at diagnosis ≥ 16) at diagnosis. Low serum C3 level was ...
We report the first case of renal antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis treated with autologous mesenchymal stromal cells (MSCs). A 73-year-old man was admitted to the hospital for malaise, weight loss, and oliguria. His se
Objective. Treatment resistance and relapse in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are major challenges for physicians. The aim of this study was to assess the risk factors for treatment resistance and relapse in a single-center cohort of Chinese patients with AAV.. Methods. Four hundred thirty-nine consecutive patients with AAV were recruited for inclusion in this study. The value of various clinical and pathologic parameters for the prediction of treatment resistance and relapse was analyzed.. Results. Treatment resistance occurred in 47 (10.7%) of 439 patients and was independently associated with a higher serum creatinine level (odds ratio [OR] 1.087, 95% confidence interval [95% CI] 1.001-1.180, P = 0.047), a higher erythrocyte sedimentation rate (OR 1.009, 95% CI 1.001-1.018, P = 0.025), therapy with corticosteroids plus cyclophosphamide (OR 0.115, 95% CI 0.051-0.256, P = 0.000), and the presence of muscle pain (OR 0.249, 95% CI 0.083-0.747, P = 0.013). ...
Wegeners granulomatosis (WG), microscopic polyangiitis (MPA) and Churg- Strauss syndrome (CSS) are small to medium-vessel vasculitides that, because of their frequent association with antineutrophil cytoplasmic antibodies (ANCA), are usually referred to as ANCA-associated systemic vasculitides (AASV). These diseases are challenging to diagnose and to treat. The diagnosis of AASV is made on the basis of clinical findings, biopsy of the involved organ and the presence of ANCA in the serum. Lung disease is a very common and important clinical feature of AASV.. Vasculitis in the lung usually involves the small vessels -arteries, capillaries and venules. Distinguishing the ANCA-associated vasculitides from other forms of vasculitis or nonvasculitic processes (such as infection) can be particularly difficult. ANCA are associated with small sized vessel vasculitis ; one subtype is an antibody against myeloperoxidase (MPO), which stains in a perinuclear pattern (P-ANCA) indirect immunofluorescence ...
We offer clinical cancer updates, treatment guidance, and research news to the oncology nursing community. Visit us often for drug therapy testing results, patient care information and more. Download our FREE app today.
ANCA vasculitis has an associated autoimmune response that produces ANCAs that induce distinct pathologic lesions. Pauci-immune necrotizing and crescentic GN is a frequent component of ANCA vasculitis. ANCA vasculitis is associated with ANCA specific for myeloperoxidase (MPO-ANCA) or proteinase 3 (PR3-ANCA). A diagnosis of ANCA vasculitis should always specify the serotype as MPO-ANCA positive, PR3-ANCA positive, or ANCA-negative. To fully characterize a patient, the serotype also should be accompanied by the clinicopathologic variant if this can be determined: microscopic polyangiitis, granulomatosis with polyangiitis (Wegener), eosinophilic granulomatosis with polyangiitis (Churg-Strauss), or renal-limited vasculitis ...
We appreciate our colleagues comments and are glad that our analysis has stimulated further thought among clinicians. We agree with Dr. Padhan that Wegener granulomatosis may be difficult to differentiate from tuberculous infection. However, studies suggest that the presence of both positive cytoplasmic ANCA by immunofluorescence and proteinase 3 enzyme-linked immunosorbent assay has a low prevalence in tuberculosis (1). Even in those rare patients in whom the diagnosis of Wegener granulomatosis is doubted and the balance of evidence favors ANCA-associated vasculitis, we believe that patients should be treated with pulse cyclophosphamide rather than with daily oral cyclophosphamide. The cumulative dose of cyclophosphamide when administered in a pulse dose is half that of the oral regimen. For example, a person who weighs 70 kg receives a 1-g pulse of cyclophosphamide over 2 weeks compared with 2 g of the oral regimen. In persons with suspected latent tuberculosis or a history of tuberculosis, ...
TY - JOUR. T1 - Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegeners granulomatosis. AU - Newman, N. J.. AU - Slamovits, T. L.. AU - Friedland, S.. AU - Wilson, W. B.. PY - 1995/1/1. Y1 - 1995/1/1. N2 - PURPOSE: Wegeners granulomatosis is classically a systemic necrotizing granulomatous vasculitis that involves the upper and lower respiratory tracts and kidneys. Ophthalmologic and neurologic manifestations are common. The limited form of Wegeners granulomatosis may have pathologic characteristics consistent with the disease but lacks the complete clinical triad. We studied the clinical, pathologic, laboratory, and radiologic findings of four patients with Wegeners granulomatosis so that others will recognize the disease, even when it occurs in its limited form. METHODS: From three clinical centers, a chart review disclosed four patients with neuroophthalmic findings and the limited form of Wegeners granulomatosis. RESULTS: Three men and one ...
Churg-Strauss disease (CSD) is one of three important fibrinoid, necrotizing, inflammatory leukocytoclastic systemic small-vessel vasculitides that are associated with antineutrophil cytoplasm antibodies (ANCAs). Of these three conditions, Churg-Strauss disease is the least commonly encountered.
Propylthiouracil (PTU) is known to induce antineutrophil cytoplasmatic antibody (ANCA) seropositivity; however, small vessel vasculitis (SVV) with pulmonary and renal involvement is rare. We present the case of an 81-year-old woman on PTU treatment due to toxic nodular goitre who developed alveolar hemorrhage and rapidly progressive glomerulonephritis. The authors highlight the importance of early recognising drug-induced pulmonary-renal syndrome (PRS) in order to avoid unnecessary tests, a delay in the diagnosis and evolution to end-stage kidney disease or life-threatening conditions.
Background. In small vessel vasculitis and its renal‐limited form, idiopathic crescentic glomerulonephritis, renal damage is characterized by pauci‐immune necrotizing crescentic glomerulonephritis (CGN) without histological evidence of immunoglobulin (Ig) deposition. In some patients, however, significant amounts of immune deposits may be detected. Therefore, we evaluated the clinical significance of these immune deposits in anti‐neutrophil cytoplasmic autoantibody (ANCA)‐associated pauci‐immune CGN.. Methods. Renal biopsies of 45 consecutive patients with new onset of Wegeners granulomatosis, microscopic polyangiitis and idiopathic CGN were retrospectively evaluated by light microscopy, immunohistochemistry and electron microscopy and the findings compared with renal function and outcome.. Results. Typical pauci‐immune CGN was found in 37 patients (group I). In eight patients (18%; group II), however, histopathological examination revealed substantial deposition of Ig in the ...
Background The gold standard to establish inflammatory bowel disease diagnosis remains in the hands of endoscopists and pathologists. A challenge is thus to distinguish symptoms of inflammatory bowel disease from that of irritable bowel syndrome. Aim of this work The aim of this study was to evaluate the clinical usefulness of fecal calprotectin level as a noninvasive marker in order to distinguish patients with diarrhea in need of intensified follow-up from those who do not need further workup. Patients and methods From a total of 150 patients presented with chronic diarrhea with or without bleeding per-rectum in the outpatient clinic of Specialized Medical Hospital, only 60 were involved in this study. Stool analysis and culture were carried out. Measurement of fecal calprotectin was done using the ELISA kit. Inflammatory biomarkers, such as erythrocyte sedimentation rate and C-reactive protein and perinuclear anti-neutrophil cytoplasmic autoantibodies (P-ANCA) and cytoplasmic antineutrophil ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Anti-neutrophil cytoplasmic autoantibodies (ANCA), targeting the neutrophil protein granules myeloperoxidase (MPO) and proteinase 3 (PR3), activate neutrophils in vitro, and are associated with a systemic autoimmune vasculitis, in which a pauci-immune crescentic glomerulonephritis is common. The in vivo study of ANCA pathogenesis is severely limited, both by the lack of a robust anti-PR3 IgG induced disease model, and by the differences found between human and mouse biology. Therefore the development of a disease model based on humanised mice, defined as mice possessing human immune cells, has the potential to overcome these limitations, while also allowing the direct study of human ANCA in vivo. The aims of this thesis were 1) to establish in vitro assays of ANCA induced neutrophil activation, and thus allow the study of ANCA:neutrophil interactions and 2) to establish a humanised mouse model of ANCA vasculitis. ANCA were purified from patient plasma, and two human neutrophil respiratory burst ...
The exact mechanism of pathogenesis for EGPA is currently unknown. However, it is generally thought to be due to a dysregulation of immune function. Research indicates that eosinophil infiltration and antineutrophil cytoplasmic antibody (ANCA)-induced endothelial damage may be involved in the underlying disease mechanism. About half of patients with EGPA have positive ANCA. Recently, it has been suggested that 2 distinct phenotypes of EGPA are present and depend on the presence or absence of ANCA. Several medications (eg, leukotriene modifying agents, omalizumab) have also been found to be associated with the apparent onset of EGPA; however, causal relationships have not been established, and it is likely that these medications only served to unmask the underlying disease ...
The Kallestad® Autoimmune ANCA IFA Complete Kits contain all necessary reagents for performing tests: human neutrophil substrate slides, FITC conjugate, PBS, mounting medium, negative and positive controls, Evans blue counterstain, cover slips and blotters. Kallestad® is the most trusted name in autoimmune testing for more than 25 years. Customers can test for p-ANCA and c-ANCA on a single slide with large cells for clear reactivity. All controls are pre-diluted and ready to use. Wells are spaced for use with a multichannel pipette. Kits are packaged for flexible volume ordering and automation options are available.. Human anti-neutrophil cytoplasmic antibodies (ANCA) are directed against antigenic components mainly present in primary granules of neutrophils. They are serological markers of primary necrotizing systemic vasculitis, particularly in granulomatosis with polyangiitis (GPA) formerly known as Wegeners granulomatosis. In addition, they have a prognostic interest because, in most ...
Background and objectives: Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA), often targeting myeloperoxidase (MPO). Cyclophosphamide (CYC) plus corticosteroids (CS) is considered standard therapy for patients with renal involvement, but treatment response is not satisfactory in all patients and CYC has well recognized toxicity. This prospective pilot trial explored whether mycophenolate mofetil (MMF) represents an effective alternative to CYC for induction and maintenance of remission in MPA with mild to moderate renal involvement.. Design, setting, participants, & measurements: Seventeen P-ANCA/MPO-ANCA-positive patients with MPA with mild to moderate renal involvement received MMF (1000 mg orally, twice daily) and CS (intravenous methylprednisolone, 1 to 3 g, followed by oral prednisone at 1 mg/kg per day). Oral CS were discontinued by month 6; MMF was continued through month 18. The primary outcome measure was ...
Wegeners granulomatosis is a condition of the immune system that causes swelling and irritation in blood vessels and other tissues.. This inflammation reduces or stops the flow of blood to organs in the body. The condition most often affects the respiratory tract-the sinuses, nose, windpipe, and lungs-and the kidneys, but it can damage any organ in the body.. Wegeners granulomatosis is uncommon. It occurs in about one out of 20,000 to 30,000 people. It can strike at any age. The cause of Wegeners granulomatosis is still unknown.. ...
Another name for Wegeners Granulomatosis is Wegeners Granulomatosis. Complications of Wegeners granulomatosis include: * Kidney failure * Skin ulcers ...
UCL Discovery is UCLs open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
en fr An Exploration of Non-Antineutrophil Cytoplasmic Antibodies Serum Biomarkers in Systemic Vasculitis : An Investigation of Behçets Disease Une exploration de biomarqueurs sériques non-anticorps anti-cytoplasme des polyn. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
Jiajin Yang, Heng Ge, Caroline J. Poulton, Susan L. Hogan, Yichun Hu, Britta E. Jones, Candace D. Henderson, Elizabeth A. McInnis, William F. Pendergraft, J. Charles Jennette, Ronald J. Falk, Dominic J. Ciavatta, Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis, Clinical Epigenetics, 2016, 8, ...
Low daily doses of oral prednisone during long-term maintenance therapy was associated with a higher rate of relapse in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan, a study reports.
Stool tests to rule out infections include culture and sensitivities, ovum and parasites, Clostridium difficile toxins, leukocyte count. Stool for calprotectin can detect active CD and also used for monitoring disease.[12][13][14][15]. Blood tests including baseline CBC and a metabolic panel can highlight the presence of anemia (B12 or iron deficiency) or liver disease. Special serology such as normal anti-neutrophil cytoplasmic antibodies (ANCA) and raised anti-saccharomyces cerevisiae antibodies (ASCA) can distinguish Crohns disease from ulcerative colitis. C-reactive protein (CRP) or sedimentary rate (ESR) can reflect the severity of the inflammation.. CT scan/MRE of the abdomen and pelvis can detect abscesses and fistulization. The choice between CT or MR enterography is largely directed at minimizing radiation exposure in younger populations. Both give a higher definition of the diseased intestine. However, MRI can provide more detail when investigating the fistulizing disease. The use of ...
Primary systemic vasculitis of small and middle large vessels (1) of unknown ethiopathogenesis is associated with anti-neutrophil cytoplasmic antibodies (ANCA). Because ANCA seem to activate directly neutrophil granulocytes which are accumulated in the lesions of small vessels and thereby initiate an inflammatory destructive process no immunoglobulins or complement components are seen in the vascular lesions (so-called "pauci-immune" vasculitis) (2, 3).. Major antigens of ANCA are: MPO,PR§, GBM all detectable with SeraSpot® Vaskulitis-3 IgG.. Principle of the test:. SeraSpot® Vaskulitis-3 IgG SIA is a solid phase immunoassay based on the use of recombinant or purified native proteins as capture antigens printed in array arrangement (spot array) on the bottom of the wells of 96well-microtitration plates. The antigens serve as capture molecules for autoantibodies against proteinase 3, myeloperoxidase and glomerular basement membrane. Bound antibodies are detected by horseradish ...
We investigated whether limited or non-renal Wegeners granulomatosis (WG) differs from classical or renal WG. Renal WG is characterized by necrotizing granulomatosis of the upper and or lower respiratory tract, accompanied by systemic vasculitis and focal segmental necrotizing glomerulonephritis. This last feature is absent in non-renal WG. In a prospective follow-up study of all identified cases presenting to a single teaching hospital, we reviewed 22 patients with non-renal WG, and compared their presentation and outcome with that of 28 patients with renal WG. Clinical and laboratory assessment of disease activity, frequency of death, relapse and end-stage renal disease were assessed. The two groups differed in clinical presentation, laboratory features and outcome. The group with non-renal WG had less cutaneous and pulmonary disease; the haemoglobin, white cell count and platelet count tended to be normal. Residual mortality was confined to the renal group. However, the groups shared many
Rhinitis is a symptomatic inflammatory disorder of the nose with different causes such as allergic, nonallergic, infectious, hormonal, drug induced, and occupational and from conditions such as sarcoidosis and necrotizing antineutrophil cytoplasmic antibodies positive (Wegeners) granulomatosis. Allergic rhinitis affects up to 40% of the population and results in nasal (ocular, soft palate, and inner ear) itching, congestion, sneezing, and clear rhinorrhea. Allergic rhinitis causes extranasal untoward effects including decreased quality of life, decreased sleep quality, obstructive sleep apnea, absenteeism from work and school, and impaired performance at work and school termed "presenteeism." The nasal mucosa is extremely vascular and changes in blood supply can lead to obstruction. Parasympathetic stimulation promotes an increase in nasal cavity resistance and nasal gland secretion. Sympathetic stimulation leads to vasoconstriction and consequent decrease in nasal cavity resistance. The nasal ...
Results Crude HP prevalence was 0.949/100 000 population. The mean age at onset was 58.3±15.8 years. Among 159 cases for whom detailed data were collated, antineutrophil cytoplasmic antibody (ANCA)-related HP was found in 54 cases (34.0%) and IgG4/multifocal fibrosclerosis (MFS)-related HP in 14 cases (8.8%). Seventy cases (44.0%) were classified as idiopathic and 21 (13.2%) as others. ANCA-related HP cases showed a female preponderance, a higher age of onset, and higher frequencies of otological symptoms and elevated systemic inflammatory biomarkers, but lower frequencies of diplopia compared with idiopathic HP. IgG4/MFS-related HP cases showed a marked male predominance; all had cranial HP while none had isolated spinal HP or decreased sensation.. ...
Introduction: Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective of this study was to evaluate the safety and clinical outcomes of rituximab in several standard-of-care-refractory autoimmune diseases (within rheumatology, nephrology, dermatology and neurology) other than rheumatoid arthritis or non-Hodgkins lymphoma in a real-life clinical setting. Methods: Patients who received rituximab having shown an inadequate response to standard-of-care had their safety and clinical outcomes data retrospectively analysed as part of the German Registry of Autoimmune Diseases. The main outcome measures were safety and clinical response, as judged at the discretion of the investigators. Results: A total of 370 patients (299 patient-years) with various autoimmune diseases (23.0% with systemic lupus erythematosus, 15.7% antineutrophil cytoplasmic antibody-associated ...
Mortality at 1 and 5 years was 23% and 40%, respectively: standardized mortality ratio, 4.74 (95% CI, 3.62-6.32). End-stage renal disease was reached by 14% and 18% at 1 and 5 years, respectively. In multivariable analysis, serum creatinine level at biopsy and percentage of normal glomeruli in the initial biopsy specimen were the best predictors of kidney survival. C Statistics were 0.80 for creatinine level alone and 0.83 for creatinine level with normal glomeruli. In patients undergoing an additional biopsy, rapid progression in the index of chronic damage and serum creatinine level at the second biopsy were associated with kidney survival in multivariable analysis ...
Glomerulonephritis and small vessel vasculitis caused by antl-neutrophil cytoplasmic autoantibodies (ANCA) is the most common cause for rapidly progressive glom...
Myeloperoxidase antibody (myeloperoxidase) for ICC/IF, IHC-Fr, IHC-P. Anti-Myeloperoxidase pAb (GTX29535) is tested in Human, Rat samples. 100% Ab-Assurance.
An elderly woman w/ history of IDA, aortic aneurysm + AI, and monoclonal gammopathy presents with SOB, found to have rapidly progressive anemia, AKI, and R,L pulmonary infiltrate concerning for a pulmonary-renal syndrome. She was ultimately diagnosed with ANCA vasculitis with +MPO, possibly related to hydralazine use and with some SLE overlap. Despite steroids and cytoxan, her renal failure progressed quickly requiring dialysis, and she ultimately transitioned to comfort care several months after the initial diagnosis ...
The increasing importance of autoimmunity based diseases attracts the interest of pathologists, for whom the wide acceptance of indirect fluorescent antibody (IFA) technique at autoantibody screening is relevant diagnostic approach. The IFA method has gained perfection by introducing the so called diagnostic mosaics, consisting of various tissue sections (primate and/or mammalian in origin), of Hep-2 cells, of microbeads (biochips) coated with specific purified antigen(s) and/or of transfected HEK cells expressing the target autoantigens. As result of this, the IFA technique dominates not only in the detection of anti-nuclear antibodies (ANA) and of anti-neutrophil cytoplasmic antibodies (ANCA), but is useful also in the search for serological markers in many other autoimmune disorders. Among diseases in question, the inflammatory bowel disease (GAB, PAB, ASCA), celiac disease (ARA, AEmA, AGA) and/or autoimmune hepatitis (AMA, ASMA, ABCA, anti-LKM1, SLA/LP) have emerged as important. ...
A 61-year-old man presented with fatigue, arthralgias and a tender rash on his ears in the setting of recent cocaine use. Physical examination revealed purpuric dark purple patches with haemorrhagic bullae on the bilateral helical rims (figures 1 and 2). Laboratory investigation was significant for a serum sodium of 130 mmol/l (normal range, 135-145) and positive perinuclear antineutrophil cytoplasmic … ...
Pulido, J.S., Goeken, J.A., Sobol, W.M., Folberg, R., Nerad, J.A. Ocular manifestations of patients with circulating anti-neutrophil cytoplasmic antibodies. Arch Ophthalmol 1990, 108, 845-850.PubMedGoogle Scholar ...
Sites throughout the U.S. and Canada are seeking patients with newly diagnosed or relapsed anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This clinical trial is designed to determine whether a new non-steroidal treatment, when added to standard of care treatment can improve the remission rate, kidney function, and/or improve vasculitis symptoms. All patients will receive standard treatment […]. more » ...
Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood...
An uncommon disease, characterized by inflammation of the blood vessels (vasculitis). Wegeners granulomatosis primarily affects the respiratory tract and the kidneys.
Wegeners granulomatosis affects the respiratory tract from the nose and sinuses to the lungs. It also affects the kidneys. This disease is a systemic inflammatory disease whereby the body creates
Common symptoms and signs symptoms of Wegeners granulomatosis are pain in the sinuses and ears; nasal congestion and discharge and nosebleeds.
Wegeners granulomatosis is a condition of the immune system. It causes swelling and irritation in blood vessels and other tissues.
The inflammation of blood vessel walls that is associated with autoimmune disorders characterized by anti-neutrophil cytoplasm antibodies (ANCA) represents dysregulation of normal physiological processes, whereby neutrophils recruited to the vessel wall by cytokine-activated endothelium show destructive behaviours that initiate damage with endothelial apoptosis and denudation. Anti-endothelial cell antibodies may also help to focus and escalate injury. Understanding the molecular mechanisms underlying the interplay between ANCA, aberrant neutrophil behaviour and vascular damage will allow development of more focused therapies ...
Anti-Myeloperoxidase antibody (ab45977) has been cited in 33 publications. References for Human, Mouse, Rat in ICC/IF, IHC, IHC-Fr, IHC-P, WB
Most CSS patients are familiar with blood tests that measure eosinophils, CRP (C-reactive protein), and sed. rate. But what is the ANCA test? Furthermore, there seemed to be some …
Allows fully automated detection of clinically relevant antibodies (anti-MPO, anti-PR3 and anti-GBM) associated with systemic small vessel vasculitis on the BioPlex 2200 system
H1 2017 Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
Myeloperoxidase (MPO) is one of the major target antigens of antineutrophil cytoplasmic antibodies (ANCA) in primary systemic vasculitis. It is known that propylthiouracil (PTU) could induce MPO-ANCA-positive vasculitis. The production of anti-MPO antibodies in patients with PTU-induced vasculitis may be different from that in patients with primary microscopic polyangiitis (MPA). One possible reason for this may be differences in epitope recognition. The aim of this study is to compare the epitopes of antibodies to MPO in sera from patients with PTU-induced vasculitis (n = 10) and MPA (n = 10). The sera were collected and used to inhibit monoclonal antibodies against human MPO (3D8 and 6B9) and affinity purified, horseradish peroxidase conjugated human anti-MPO antibodies (Pab1-HRP, Pab2-HRP) in a competitive inhibition enzyme-linked immunosorbent assay (ELISA) system using soluble human MPO as solid phase ligand. The Pab1-HRP and Pab2-HRP were affinity purified from plasma exchanges of a ...
Cytoplasmic staining (c-ANCA) is frequently associated with antiproteinase 3 antibody and in an appropriate clinical context consistent with renal vasculitis, is a sensitive and specific test for Wegeners granulomatosis. Classical perinuclear staining (p-ANCA)is associated with antimyeloperoxidase antibody and microscopic polyangiitis. Atypical patterns occur in a range of diseases including inflammatory bowel disease and other autoimmune diseases. Antinuclear antibody interferes with determination of pattern.. Positive immunoassays especially at higher titre in general correlate with the presence of systemic necrotizing vasculitis.. In a suggestive clinical context, ANCA positivity should be used to select those patients requiring more intensive investigation, including renal biopsy, to exclude systemic necrotizing vasculitis. Atypical ANCA is associated with a variety of diseases other than vasculitis. A negative ANCA result does not exclude the diagnosis of systemic necrotizing ...
part of that is self education. IF you read only one thing about your ANCA related Vasculitis all year… then THIS should be it. Seriously, not kidding.. First off Granulomatosis with polyangiitis (GPA, Wegeners granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome) are termed the antineutrophil cytoplasmic antibody (ANCA)- associated vasculitides. Even IF you are ANCA Negative (50% of CSS/EGPA patients you are still considered to have an ANCA Associated Vasculitis.. On June 23rd, 2016 a new document was published that updated the guidelines for treatment of ANCA Associated Vasculitis. This was the first major revision of treatment guidelines since 2009 and in many ways it is a game changer because of the newer biological medicines. It was created by European League Against Rheumatism (EULAR). Which includes doctors, nurses, researchers and even a patient.. Fifteen recommendations were developed, covering general ...
Looking for online definition of acute crescentic glomerulonephritis in the Medical Dictionary? acute crescentic glomerulonephritis explanation free. What is acute crescentic glomerulonephritis? Meaning of acute crescentic glomerulonephritis medical term. What does acute crescentic glomerulonephritis mean?
John W. Stirling and Alan Curry. 1.1 The Role of Transmission Electron Microscopy (TEM) in Renal Diagnostics 1. 1.2 Ultrastructural Evaluation and Interpretation 2. 1.3 The Normal Glomerulus 3. 1.4 Ultrastructural Diagnostic Features 5. 1.5 Granular and Amorphous Deposits 6. 1.6 Organised Immune-Related Fibrils and Tubules 7. 1.7 Nonspecific Fibrils 11. 1.8 General and Nonspecific Inclusions and Deposits 11. 1.9 Fibrin 12. 1.10 Tubuloreticular Bodies (Tubuloreticular Inclusions) 12. 1.11 The Glomerular Basement Membrane 13. 1.12 The Mesangial Matrix 14. 1.13 Cellular Components of the Glomerulus 14. 1.14 Mesangial Cells 16. 1.15 The Capillary Lumen 16. 1.16 The Ultrastructural Pathology of the Major Glomerular Diseases 16. 1.17 Focal Segmental Glomerulosclerosis 17. 1.18 Pauci-Immune Glomerulonephritis (ANCA-Associated Glomerulonephritis) 18. 1.19 Anti-GBM Glomerulonephritis (Goodpasture Syndrome) 19. 1.20 Diseases with Structural GBM Changes 19. 1.21 Thin Basement Membrane Disease 21. 1.22 ...
TY - JOUR. T1 - Diffuse alveolar hemorrhage due to antibasement membrane antibody disease appearing with a polyglandular autoimmune syndrome. AU - Moss, M.. AU - Neff, T. A.. AU - Colby, T. V.. AU - Schwarz, M. I.. AU - Zamora, M. R.. PY - 1994. Y1 - 1994. N2 - We describe a patient with type 3-C polyglandular autoimmune syndrome who presented with diffuse alveolar hemorrhage and normal renal function. The diagnosis of antibasement membrane antibody disease was established by immunofluorescent staining of transbronchial biopsy specimens. We suggest the incorporation of antibasement membrane antibody disease into the spectrum of diseases that define the polyglandular autoimmune syndromes.. AB - We describe a patient with type 3-C polyglandular autoimmune syndrome who presented with diffuse alveolar hemorrhage and normal renal function. The diagnosis of antibasement membrane antibody disease was established by immunofluorescent staining of transbronchial biopsy specimens. We suggest the ...
A 55-year-old man was admitted with paralysis of the left lower leg. He had purpura in the left lower extremity for three years, left calf pain for two years, and dysesthesia in the left plantar region and first toe for one year. A physical examination revealed livedo reticularis on the left leg and mononeuritis multiplex was diagnosed in the bilateral tibial and left peroneal nerve area. Anti-neutrophil cytoplasmic antibody was negative. A nerve conduction study showed decreased amplitude of compound muscle-action potential in the bilateral tibial and the left peroneal nerve, sensory nerve action potential in the bilateral sural nerve ...

Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa - Mayo ClinicDetermining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa - Mayo Clinic

Presence of antiproteinase 3 or antimyeloperoxidase antineutrophil cytoplasmic antibodies (ANCA). *Glomeronephritis. *Alveolar ...
more infohttp://www.mayo.edu/research/clinical-trials/cls-20147704

Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody...Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody...

Renal failure is also uncommon as an adverse event of anti-epidermal growth factor receptor antibody. A 67-year-old Japanese ... However, there are few reports of purpura induced by anti-epidermal growth factor receptor antibody. ... Panitumumab is the first human combinatorial antibody for the treatment of metastatic colorectal carcinoma. Dermatologic ... proteinase 3-antineutrophil cytoplasmic antibody (PR3-ANCA), and myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA ...
more infohttps://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-018-1877-7

Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegeners granulomatosis<...Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis<...

In all patients, results of antineutrophil cytoplasmic antibody tests were initially negative but in one patient were positive ... In all patients, results of antineutrophil cytoplasmic antibody tests were initially negative but in one patient were positive ... In all patients, results of antineutrophil cytoplasmic antibody tests were initially negative but in one patient were positive ... In all patients, results of antineutrophil cytoplasmic antibody tests were initially negative but in one patient were positive ...
more infohttps://einstein.pure.elsevier.com/en/publications/neuro-ophthalmic-manifestations-of-meningocerebral-inflammation-f-2

Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic AntibodiesNovel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies

... Johannes Schulte-Pelkum,1 Antonella Radice,2 ... "Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies," Journal of Immunology Research, vol. 2014, ...
more infohttps://www.hindawi.com/journals/jir/2014/185416/cta/

Antineutrophil cytoplasmic antibodies - RightDiagnosis.comAntineutrophil cytoplasmic antibodies - RightDiagnosis.com

Antineutrophil cytoplasmic antibodies information including symptoms, causes, diseases, symptoms, treatments, and other medical ... Antineutrophil cytoplasmic antibodies. Description of Antineutrophil cytoplasmic antibodies. Antineutrophil cytoplasmic ... Terms associated with Antineutrophil cytoplasmic antibodies:. Terms Similar to Antineutrophil cytoplasmic antibodies:. *ANCA ... External links related to: Antineutrophil cytoplasmic antibodies. *ANCA (Anti-Neutrophilic Cytoplasmic Antibodies) Source: ...
more infohttps://www.rightdiagnosis.com/medical/antineutrophil_cytoplasmic_antibodies.htm

What Is an Antineutrophil Cytoplasmic Antibody? (with pictures)What Is an Antineutrophil Cytoplasmic Antibody? (with pictures)

An antineutrophil cytoplasmic antibody is a type of protein that is produced by the bodys immune system and is associated with ... An antineutrophil cytoplasmic antibody (ANCA) is a protein produced by the bodys immune system, and it is associated with a ... The antineutrophil cytoplasmic antibody is one of these autoantibodies, as it represents the body attacking its own neutrophils ... Whether a person is producing an antineutrophil cytoplasmic antibody can be evaluated by checking a sample of the blood. Often ...
more infohttps://www.wisegeek.com/what-is-an-antineutrophil-cytoplasmic-antibody.htm

Antineutrophil Cytoplasmic Antibody Frequency in Chronic Hepatitis B PatientsAntineutrophil Cytoplasmic Antibody Frequency in Chronic Hepatitis B Patients

... Turan Calhan,1 Abdurrahman Sahin,1 Resul ... Turan Calhan, Abdurrahman Sahin, Resul Kahraman, et al., "Antineutrophil Cytoplasmic Antibody Frequency in Chronic Hepatitis B ...
more infohttps://www.hindawi.com/journals/dm/2014/982150/cta/

Antineutrophil Cytoplasmic Antibodies (ANCA) Test: MedlinePlus Lab Test InformationAntineutrophil Cytoplasmic Antibodies (ANCA) Test: MedlinePlus Lab Test Information

This test looks for antineutrophil cytoplasmic antibodies (ANCA) in your blood. If ANCAs are found, you may have autoimmune ... What is an antineutrophil cytoplasmic antibodies (ANCA) test?. This test looks for antineutrophil cytoplasmic antibodies (ANCA ... medlineplus.gov/lab-tests/antineutrophil-cytoplasmic-antibodies-anca-test/ Antineutrophil Cytoplasmic Antibodies (ANCA) Test. ... Antineutrophil Cytoplasmic Antibodies (ANCA). Autoimmunity [Internet]. 2005 Feb [cited 2019 May 3]; 38(1): 93-103. Available ...
more infohttps://medlineplus.gov/lab-tests/antineutrophil-cytoplasmic-antibodies-anca-test/

Antineutrophil Cytoplasmic Antibodies
      - ANCA
     Summary Report | CureHunterAntineutrophil Cytoplasmic Antibodies - ANCA Summary Report | CureHunter

ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA ( ... Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as ... ANCA; Anti-Neutrophil Cytoplasmic Antibody; Antineutrophil Cytoplasmic Antibody; Antibodies, Antineutrophil Cytoplasmic; Anti- ... Anti Neutrophil Cytoplasmic Antibodies; Anti Neutrophil Cytoplasmic Antibody; Antibodies, Anti-Neutrophil Cytoplasmic; Antibody ...
more infohttp://www.curehunter.com/public/keywordSummaryD019268-Antineutrophil-Cytoplasmic-Antibodies-ANCA.do

Antineutrophil cytoplasmic antibodies: appropriate use and interpretation | Annals of the Rheumatic DiseasesAntineutrophil cytoplasmic antibodies: appropriate use and interpretation | Annals of the Rheumatic Diseases

It was with much interest that we read the letter of Novikov et al 1 on testing for antineutrophil cytoplasmic antibodies ( ... Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases. Ann Rheum ... Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Am J Clin Pathol 2014;66:1672-7. ... Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of ...
more infohttp://ard.bmj.com/content/76/8/e24

Anti-neutrophil cytoplasmic antibody - WikipediaAnti-neutrophil cytoplasmic antibody - Wikipedia

Sinclair, D; Stevens, JM (Sep 2007). "Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies ... Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies, mainly of the IgG type, against antigens in the ... images of pANCA and cANCA fluorescence images of ANCA Anti-Neutrophil Cytoplasmic Antibody at the US National Library of ... Savige, J; Davies, D; Falk, RJ; Jennette, JC; Wiik, A (Mar 2000). "Antineutrophil cytoplasmic antibodies and associated ...
more infohttps://en.wikipedia.org/wiki/Anti-neutrophil_cytoplasmic_antibody

Anti-Neutrophil Cytoplasmic Antibody - DrugBankAnti-Neutrophil Cytoplasmic Antibody - DrugBank

Anti-Neutrophil Cytoplasmic Antibody. *Drug Trials. Drug. Drug Name. Drug Description. Drug. Drug Name. Target. Type. ...
more infohttps://www.drugbank.ca/indications/DBCOND0034726

Segmental testicular infarction due to minocycline-induced antineutrophil cytoplasmic antibody--positive vasculitis. | Sigma...Segmental testicular infarction due to minocycline-induced antineutrophil cytoplasmic antibody--positive vasculitis. | Sigma...

We present a unique case of testicular infarct caused by an antineutrophil cytoplasmic antibody-positive vasculitis secondary ... Segmental testicular infarction due to minocycline-induced antineutrophil cytoplasmic antibody--positive vasculitis.. [Timothy ...
more infohttps://www.sigmaaldrich.com/catalog/papers/24793001

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome | BMJ Case ReportsHydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome | BMJ Case Reports

Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of ... antihistone antibody, antielastase antibody and antiphospholipid antibody.15 17 Antihistone antibody is commonly seen with drug ... To date, there have been only 10 reported cases of diabetic nephropathy with antineutrophil cytoplasmic antibodies mediated ... Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary ...
more infohttps://casereports.bmj.com/content/2018/bcr-2018-227161

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome | BMJ Case ReportsHydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome | BMJ Case Reports

You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our cookies policy. ...
more infohttps://casereports.bmj.com/content/2018/bcr-2018-227161.altmetrics

Various Forms of Life in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | Annals of Internal Medicine | American...Various Forms of Life in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | Annals of Internal Medicine | American...

Antineutrophil Cytoplasmic Antibodies and the Churg-Strauss Syndrome Are There Different Forms of Life in the Antineutrophil ... Various Forms of Life in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Gary S. Hoffman, MD, MS; Carol A. Langford, ... Various Forms of Life in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Ann Intern Med. ;144:378-379. doi: 10.7326/ ... Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic Antibody-Associated Small-Vessel Vasculitis ...
more infohttps://annals.org/aim/article-abstract/721074/various-forms-life-antineutrophil-cytoplasmic-antibody-associated-vasculitis

anti-neutrophil cytoplasmic antibodies (ANCA) Archives - The Rheumatologistanti-neutrophil cytoplasmic antibodies (ANCA) Archives - The Rheumatologist

Articles tagged with "anti-neutrophil cytoplasmic antibodies (ANCA)". Study Probes Whether Belimumab Can Lower Vasculitis ... anti-neutrophil cytoplasmic antibodies (ANCA). ...
more infohttps://www.the-rheumatologist.org/tag/anti-neutrophil-cytoplasmic-antibodies-anca/

Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases | Annals of...Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases | Annals of...

Antineutrophil cytoplasmic antibodies: appropriate use and interpretation. Jan Damoiseaux Elena Csernok Niels Rasmussen Jan- ... Antineutrophil cytoplasmic antibodies associated with infective endocarditis. Medicine (Baltimore) 2016;95: e2564. doi:10.1097/ ... Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of ... Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases ...
more infohttp://ard.bmj.com/content/76/8/e23

Borderline positive antineutrophil cytoplasmic antibodies (ANCA)-PR3/MPO detection in a large cohort tertiary center: lessons...Borderline positive antineutrophil cytoplasmic antibodies (ANCA)-PR3/MPO detection in a large cohort tertiary center: lessons...

... are the best strategies for antineutrophil cytoplasmic antibodies (ANCA) detection. In a minority of subjects, ELISA-based ANCA ... Four MPO-ANCA (9.30%) and 11 PR3-ANCA (11.70%) antibody borderline samples resulted positive on IIF testing. Subjects with ... and of 14,555 MPO-ANCA antibody tests, 43 were borderline positive (titre 0.9-1.1). The male-to-female ratio was 1:1.08 and the ... Of the 14,555 PR3-ANCA antibody tests that were performed, 94 were borderline positive (titre 0.9-1.1), ...
more infohttps://www.degruyter.com/view/j/cclm.2018.56.issue-6/cclm-2017-1053/cclm-2017-1053.xml?format=INT

Antineutrophil Cytoplasmic Antibodies (ANCA) Blood TestAntineutrophil Cytoplasmic Antibodies (ANCA) Blood Test

Order a Antineutrophil Cytoplasmic Antibodies (ANCA) Blood Test online. Order & save when you buy directly without insurance or ... Antineutrophil cytoplasmic autoantibodies (ANCA) are a serological marker associated with vasculitis and glomerulonephritis.. ... Antineutrophil cytoplasmic autoantibodies exhibiting pANCA or cANCA patterns are detected using indirect immunofluorescent ... in order to differentiate the presence of true pANCA antibodies from possible interference with antinuclear antibodies (ANA). ...
more infohttps://www.walkinlab.com/antineutrophilcytoplasmicantibodies-anca-blood.html

Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe? | Annals of Internal Medicine | American...Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe? | Annals of Internal Medicine | American...

Antineutrophil Cytoplasmic Antibodies and the Churg-Strauss Syndrome Various Forms of Life in Antineutrophil Cytoplasmic ... Antineutrophil Cytoplasmic Antibodies and the Churg-Strauss Syndrome Annals of Internal Medicine; 143 (9): 632-638 ... What do antineutrophil cytoplasmic antibodies (ANCAs) tell us about a patient with vasculitis? Does ANCA or the antigen that it ... Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe? Gary S. Hoffman, MD, MS; Carol A. ...
more infohttp://annals.org/aim/article-abstract/718816/different-forms-life-antineutrophil-cytoplasmic-antibody-universe

Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic...Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic...

Antibodies, Antineutrophil Cytoplasmic / blood*. Giant Cell Arteritis / blood, complications, pathology. Humans. Macrophage ... 0/Antibodies, Antineutrophil Cytoplasmic; 0/Macrophage Migration-Inhibitory Factors; EC 1.11.1.7/Peroxidase; EC 3.4.21.-/Serine ... that MIF contributes to the inflammatory process and correlates with disease activity in antineutrophil cytoplasmic antibody- ... between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody- ...
more infohttp://www.biomedsearch.com/nih/Relationship-between-serum-levels-macrophage/16391884.html

Wegeners granulomatosis (anti-neutrophil cytoplasmic antibody, ANCA-associated vasculitis) - ONAWegener's granulomatosis (anti-neutrophil cytoplasmic antibody, ANCA-associated vasculitis) - ONA

Wegeners granulomatosis (anti-neutrophil cytoplasmic antibody, ANCA-associated vasculitis). Are You Confident of the Diagnosis ... Anti-Neutrophils Cytoplasmic Antibodies (ANCA) Associated Vasculitis. *Serum HPV Antibody Levels May Be a Biomarker for ... a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status". J Cutan Pathol. vol. ... "Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive ...
more infohttp://www.oncologynurseadvisor.com/dermatology/wegeners-granulomatosis-anti-neutrophil-cytoplasmic-antibody-anca-associated-vasculitis/article/592194/

Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. | Journal...Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. | Journal...

AIMS--To study the effect of proctocolectomy on the antineutrophil cytoplasmic antibody (ANCA) titres in association with ... Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. ... Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. ... RESULTS--Before proctocolectomy, 13 of the 15 patients had perinuclear antineutrophil cytoplasmic antibodies (p-ANCA). ...
more infohttp://jcp.bmj.com/content/48/7/645

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis | The...OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis | The...

Objective. The antineutrophil cytoplasmic antibody-associated vasculitides (AAV) are multiorgan diseases. Patients with AAV ... OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis. ... OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis ... OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis ...
more infohttp://www.jrheum.org/content/44/10/1529
  • Panitumumab is the first human combinatorial antibody for the treatment of metastatic colorectal carcinoma. (biomedcentral.com)
  • Panitumumab is a fully humanized antibody for the treatment of RAS wild-type metastatic colorectal carcinoma (mCRC). (biomedcentral.com)
  • Distinguishing between these two classes depends on a laboratory study that localizes what part of the neutrophil the antibody is attacking. (wisegeek.com)